BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22808340)

  • 21. Structural dynamics of GluK2 kainate receptors in apo and partial agonist bound states.
    Bogdanović N; Segura-Covarrubias G; Zhang L; Tajima N
    Res Sq; 2023 Dec; ():. PubMed ID: 38076992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exciting Times: New Advances Towards Understanding the Regulation and Roles of Kainate Receptors.
    Evans AJ; Gurung S; Henley JM; Nakamura Y; Wilkinson KA
    Neurochem Res; 2019 Mar; 44(3):572-584. PubMed ID: 29270706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kainate receptors GluK1 and GluK2 differentially regulate synapse morphology.
    Duan GF; Tang XH; Jia M; Wu D; Shi YS
    Synapse; 2023 Jan; 77(1):e22255. PubMed ID: 36121930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neto2 Assembles with Kainate Receptors in DRG Neurons during Development and Modulates Neurite Outgrowth in Adult Sensory Neurons.
    Vernon CG; Swanson GT
    J Neurosci; 2017 Mar; 37(12):3352-3363. PubMed ID: 28235897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elfn1-Induced Constitutive Activation of mGluR7 Determines Frequency-Dependent Recruitment of Somatostatin Interneurons.
    Stachniak TJ; Sylwestrak EL; Scheiffele P; Hall BJ; Ghosh A
    J Neurosci; 2019 Jun; 39(23):4461-4474. PubMed ID: 30940718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assembly and intracellular distribution of kainate receptors is determined by RNA editing and subunit composition.
    Ball SM; Atlason PT; Shittu-Balogun OO; Molnár E
    J Neurochem; 2010 Sep; 114(6):1805-18. PubMed ID: 20626562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310.
    Atlason PT; Scholefield CL; Eaves RJ; Mayo-Martin MB; Jane DE; Molnár E
    Mol Pharmacol; 2010 Dec; 78(6):1036-45. PubMed ID: 20837679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amino-terminal domains of kainate receptors determine the differential dependence on Neto auxiliary subunits for trafficking.
    Sheng N; Shi YS; Nicoll RA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1159-1164. PubMed ID: 28100490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative analysis of kainate receptor GluK2 and GluK5 knockout mice in a pure genetic background.
    Iida I; Konno K; Natsume R; Abe M; Watanabe M; Sakimura K; Terunuma M
    Behav Brain Res; 2021 May; 405():113194. PubMed ID: 33631192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Antiseizure Drug Perampanel Is a Subunit-Selective Negative Allosteric Modulator of Kainate Receptors.
    Taniguchi S; Stolz JR; Swanson GT
    J Neurosci; 2022 Jul; 42(28):5499-5509. PubMed ID: 35654603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agonist binding to the GluK5 subunit is sufficient for functional surface expression of heteromeric GluK2/GluK5 kainate receptors.
    Fisher JL; Housley PR
    Cell Mol Neurobiol; 2013 Nov; 33(8):1099-108. PubMed ID: 23975096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of kainate receptors in inner and outer hair cell synapses.
    Fujikawa T; Petralia RS; Fitzgerald TS; Wang YX; Millis B; Morgado-Díaz JA; Kitamura K; Kachar B
    Hear Res; 2014 Aug; 314():20-32. PubMed ID: 24858010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyrosine phosphorylation of GluK2 up-regulates kainate receptor-mediated responses and downstream signaling after brain ischemia.
    Zhu QJ; Kong FS; Xu H; Wang Y; Du CP; Sun CC; Liu Y; Li T; Hou XY
    Proc Natl Acad Sci U S A; 2014 Sep; 111(38):13990-5. PubMed ID: 25201974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subunit-specific desensitization of heteromeric kainate receptors.
    Mott DD; Rojas A; Fisher JL; Dingledine RJ; Benveniste M
    J Physiol; 2010 Feb; 588(Pt 4):683-700. PubMed ID: 20026616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subunit-dependent modulation of kainate receptors by muscarinic acetylcholine receptors.
    Benveniste M; Wilhelm J; Dingledine RJ; Mott DD
    Brain Res; 2010 Sep; 1352():61-9. PubMed ID: 20655886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotection of GluK1 kainate receptor agonist ATPA against ischemic neuronal injury through inhibiting GluK2 kainate receptor-JNK3 pathway via GABA(A) receptors.
    Lv Q; Liu Y; Han D; Xu J; Zong YY; Wang Y; Zhang GY
    Brain Res; 2012 May; 1456():1-13. PubMed ID: 22516108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kainate Receptors: Role in Epilepsy.
    Falcón-Moya R; Sihra TS; Rodríguez-Moreno A
    Front Mol Neurosci; 2018; 11():217. PubMed ID: 29988380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained postsynaptic kainate receptor activation downregulates AMPA receptor surface expression and induces hippocampal LTD.
    Nair JD; Braksator E; Yucel BP; Fletcher-Jones A; Seager R; Mellor JR; Bashir ZI; Wilkinson KA; Henley JM
    iScience; 2021 Sep; 24(9):103029. PubMed ID: 34553130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neurotoxin domoate causes long-lasting inhibition of the kainate receptor GluK5 subunit.
    Fisher JL
    Neuropharmacology; 2014 Oct; 85():9-17. PubMed ID: 24859608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contributions of different kainate receptor subunits to the properties of recombinant homomeric and heteromeric receptors.
    Fisher MT; Fisher JL
    Neuroscience; 2014 Oct; 278():70-80. PubMed ID: 25139762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.